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Accepted 22 January 2012; Published online 3 May 2012AbstractObjective: The increasing prevalence of diabetes suggests a gap between real world and controlled trial effectiveness of lifestyle in-
terventions, but real-world investigations are rare. Electronic medical registration facilitates research on real-world effectiveness, although
such investigations may require specific methodology and statistics. We investigated the effects of real-world primary care for patients with
type 2 diabetes mellitus (T2DM).
Study Design and Setting: We used medical records of patients (n5 2,549) with T2DM from 10 primary health care centers. A mixed-
effects regression model for repeated measurements was used to evaluate the changes in weight and Hemoglobin A1c (HbA1c) over time.
Results: There was no statistically significant change in weight (þ0.07 kg, P5 0.832) and HbA1c (þ0.03%, P5 0.657) during the
observation period of 972 days. Most patients maintained their physical activity level (70%), and 54 % had an insufficient activity level.
The variability in the course of weight and HbA1c was because of differences between patients and not between health care providers.
Conclusion: Despite effective lifestyle interventions in controlled trial settings, we found that real-world primary care is only able to
stabilize weight and HbA1c in patients with T2DM over time. Medical registration can be used to monitor the actual effectiveness of in-
terventions in primary care.  2012 Elsevier Inc. All rights reserved.
Keywords: Primary health care; Electronic health records; Diabetes mellitus, type 2; Health care quality, access, and evaluation; Lifestyle; Translational research1. Introduction
It is well known that the number of patients diagnosed
with type 2 diabetes mellitus (T2DM) has grown consider-
ably and that T2DM has become a substantial medical and
financial problem [1e3]. T2DM has high morbidity and
mortality rates because of nephropathy, retinopathy, neu-
ropathy, and increased risk of cardiovascular disease. Of
all deaths, 5.2% are estimated to be attributable to diabetes
in general, projecting it to be the fifth leading cause of
death in the world [4].
Weight loss and increases in physical activity (PA) are
considered to be the cornerstones in the prevention and
treatment of T2DM [5e8]. Intensive lifestyle interventions* Corresponding author. Tel.: þ31-(0)-43-388-4186; fax: þ31-(0)-43-
361-9344.
E-mail address: joris.linmans@maastrichtuniversity.nl (J.J. Linmans).
0895-4356/$ - see front matter  2012 Elsevier Inc. All rights reserved.
doi: 10.1016/j.jclinepi.2012.01.010have been shown to decrease the likelihood of developing
T2DM in patients with prediabetes, improve glycemic con-
trol, and reduce risk factors for cardiovascular disease
[9e11]. In addition, marked weight loss after bariatric
surgery can in fact produce remission of T2DM [12].
Considering the availability of lifestyle programs and at-
tempts to implement these programs into primary health
care [13e21], one would like to observe a decrease in the
prevalence of T2DM. However, the prevalence of T2DM
is still increasing rapidly [1e3]. This may imply that care
outside the randomized trial setting is not as effective as
in real-world settings and/or that translation of evidence
into usual primary care is difficult [22]. Investigating the
real-world effects of lifestyle interventions in primary care
is often not possible because of the fact that outcome mea-
sures are not routinely recorded. Many randomized trials
have a ‘‘usual care’’ control group, but this may not be
an appropriate reflection of the real usual care as people
can act differently in a research setting [23]. In addition,
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 There is an urgent need of lifestyle programs de-
veloped and proven effective in primary care to re-
ally intervene in the worldwide diabetes pandemic.
 More studies should be performed in primary care
networks with solid medical registration systems.
 Primary care is only able to stabilize weight and
Hemoglobin A1c in patients with type 2 diabetes
mellitus.
 Most patients with T2DM have an insufficient
physical activity level.
 Translating evidence from lifestyle programs from
research settings into real-world settings remains
challenging.
randomized trials often use highly selected populations
[24e26]. Therefore, studies from real-world primary care
are needed. To be able to intervene in the diabetes pan-
demic, we need to solve the puzzle of the evidence gap be-
tween effectiveness in trial settings and primary care
settings.
Because of electronic medical registration in primary
care, detailed information about the quality of care for pa-
tients with T2DM becomes increasingly available [27e29].
Studies using these databases can provide a realistic bench-
mark of the current effects of T2DM primary health care,
so that the magnitude of the challenge to improve lifestyle
becomes clear for health care providers, researchers, and
policy makers.
We examined a cohort of approximately 2,500 patients
with T2DM in a real-world primary care setting over a pe-
riod of 972 days. The aim of the study was to determine the
effects of the currently provided care on the course of
weight and Hemoglobin A1c (HbA1c) to illustrate a part
of the puzzle of translating evidence into daily practice.
In addition, we propose a statistical solution to analyze
the hierarchical data in the course of time.2. Methods
2.1. Setting
We conducted the study in collaboration with Corporation
of Primary Health Care Centers, Eindhoven (SGE). SGE in-
cludes 10 primary health care centers, 45 general practi-
tioners, and approximately 60,000 patients in a semi-large
city in the Netherlands. We performed a retrospective longi-
tudinal analysis among patients with T2DM receiving usual
care at one of the SGE centers using electronic primary care
medical records for data abstraction.2.2. Description of the diabetes management program
in usual care
In SGE, a diabetes management program was imple-
mented in 2007. According to this program, patients have
regular checks four times per year; every 3 months with a di-
abetes practice nurse (DPN) (three times per year) and annu-
ally with the general practitioner. Several variables are
measured at every visit, including blood pressure, weight,
body mass index (BMI), fasting glucose level (capillary
blood), smoking and alcohol habits, disease experience,
and medication and diet compliance. During the diabetes
checkups, the DPN also asks the patients about their PA.
Based on the responses, patients are classified into three
levels: ‘‘Healthy’’ (Dutch Standard for Healthy Physical Ac-
tivity), meaning that the patient moves 5 days per week 30
minutes at moderate intensity (e.g., dancing, gardening,
and brisk walking), ‘‘Deficient,’’ which means being less ac-
tive than those in the ‘‘Healthy’’ level, and ‘‘Sportive,’’
meaning more active than those in the ‘‘Healthy’’ level and
that the patient moves at least three times per week 20 min-
utes at high intensity (e.g., intensive fitness and intensive cy-
cling). Once per year, HbA1c level, blood lipid levels, renal
function, eyes, feet, and abdominal circumference are
checked. When necessary, extra checkups can be performed
in between the regular quarterly consultations.
Every person with diabetes receives lifestyle advice from
the DPN. In the first months after diagnosis and when insulin
treatment is started, patients with T2DM go to a dietician for
a consultation on nutritional advice. After consulting the di-
etician, nutritional advice is provided by the DPN during the
regular checks. People with a BMIO 25 kg/m2 are encour-
aged to lose weight. If patients are motivated, they are re-
ferred to a physiotherapist to assist them in increasing
their PA level. The physiotherapists, employed by SGE, have
been trained in motivational interviewing and specific PA
programs for diabetics.2.3. Study population and data collection
Data on diabetes indicators measured during the quar-
terly checks were collected from the 1st of January 2007
(implementation of the diabetes management program) to
the 1st of September 2009 and abstracted from electronic
primary care medical records. Study subjects were selected
using the International Classification of Primary Care-
codes T90 (diabetes), T90.1 (type 1 diabetes), and T90.2
(type 2 diabetes) (Fig. 1). We only used patients from nine
health care centers as at the time, one center had just started
and provided diabetes care for only five patients (only two
of which had usable data). Patients who received diabetes
care primarily in the hospital (medical specialist) had an
additional code in the general practitioner’s registration
system and were excluded from analyses, as well as pa-
tients with type 1 diabetes. Patients with code T90 could
be with either type 1 or type 2 diabetes. However, if
Fig. 1. Flow of included patients for weight analysis and Hemoglobin
Alc (HbA1c) analysis (ICPC: International Classification of Primary
Care).
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had no additional code for hospital diabetes care, they were
included in the analyses, and we assumed that these pa-
tients had T2DM. In addition, we excluded patients for
whom we had no more data than age and gender. The indi-
vidual observation periods vary as patients could have been
diagnosed with T2DM later than January 2007 or could
have moved or died before September 2009.
2.4. Statistical analysis
We first examined the data visually, by plotting the re-
peated measurements of weight and HbA1c over time. A
loess smoother [30] was added to the plot to providea model-free summary of the overall trend in the data.
We then examined individual trajectories for the subjects.
For weight, the repeated measurements appeared to be well
approximated by linear trends. This also was true for the
HbA1c measurements for most patients. However, a number
of patients who were registered after January 1, 2007
showed a rapid decline in HbA1c levels at the start
(a hockey-stick phenomenon), probably because of the
commencement of medical treatment. Neither a linear nor
a quadratic trend approximated the HbA1c measurements
adequately for these individuals. Moreover, because the
change point varied for these individuals and the use of
a random change point model proved not suitable, we de-
cided to analyze the HbA1c measurements only for those
patients with a registration date at SGE before January
1, 2007.
To account for the hierarchical structure of the data (re-
peated measurements nested within patients, which in turn
were nested within general practitioners, which in turn
were nested within health care centers) and to properly dis-
tinguish within-person changes and between-person differ-
ences, we used a mixed-effects regression model for
repeated measurements to evaluate the changes in weight
and HbA1c in the course of time [31]. The analyses were
conducted with the statistical software R (v 2.14.1; R foun-
dation for Statistical Computing, Vienna, Austria), using
the nlme package [32]. The primary predictor of interest
was time (i.e., the number of days within the follow-up pe-
riod subsequent to the first measurement day within the
follow-up period), which was included in the model as
a time-varying covariate. Age (at the first measurement
occasion), gender, initial PA level, and the day of the first
measurement within the follow-up period for each indivi-
dual patient were taken into account as time invariant
covariates. Because we were studying an open cohort in
a natural setting, we coded time in an absolute manner.
For example, the day of the first measurements would be
coded as 15 for a patient measured for the first time on Jan-
uary 16, 2007 (January 1, 2007 corresponds to day 0) and
subsequent measurements are then coded as the number
of days passed since that day (e.g., 64 days for a second
measurement taken on March 20, 2007).
Moreover, we selected the first and the last observation
of the initial PA level (three categories) within each per-
son’s individual follow-up period and used the transition
between both observations to define nine categories of
changes in PA level (PA-change level). We then examined
whether age, gender, and the PA-change level interacted
with time, that is, whether changes in weight and HbA1c
differed as a function of these variables. For age, polyno-
mials up to the third degree also were examined to deter-
mine whether this variable exerted a nonlinear influence
on the dependent variable. Finally, we included random ef-
fects for the intercept and the slope of time on the person,
general practitioner, and center levels of the hierarchical
model. However, because the variability in the intercepts
788 J.J. Linmans et al. / Journal of Clinical Epidemiology 65 (2012) 785e792and slopes was essentially zero at the center level, we drop-
ped this level from the model.Fig. 2. Percentages of patients in the nine categories of changes in
physical activity (PA) level. (1) Healthy: moving 5 days per week at
least 30 minutes at moderate intensity (e.g., dancing, gardening,
and brisk walking); (2) Deficient: being less active than the patients
in the Healthy level; (3) Sportive: moving at least three times per week
20 minutes at high intensity (e.g., intensive fitness and intensive cy-
cling). The percentages of patients who maintain their PA level are
presented within the squares. Data on PA levels were unavailable
for 610 patients.3. Results
During the observation period of 972 days, we included
2,549 patients with T2DM (Fig. 1). The baseline character-
istics of these 2,549 patients at study entry are shown in
Table 1. The percentages of patients in the nine categories
of changes in PA level are displayed in Fig. 2. This figure
shows that over 51% (40.1þ 0.8þ 10.2) of the patients
had a ‘‘Deficient’’ initial PA level and 54% (40.1þ
1.4þ 12.8) had a ‘‘Deficient’’ level at the end of the obser-
vational period. In total, 12% of the patients increased their
PA level, 17% decreased, and 70% maintained their PA
level. Only 7% had a ‘‘Sportive’’ initial PA level, and only
2% increased their activity to a ‘‘Sportive’’ PA level,
whereas 5% decreased their activity to a lower level than
‘‘Sportive.’’ All measurements of weight and HbA1c over
time are plotted in Figs. 3 and 4. Four individual trajectories
are added to the figures for illustration purposes. A loess
smoother was added to visualize the model-free overall
trend of the weight and HbA1c data. The smoothers show
that the overall trend is practically horizontal.
For the analyses of the changes in weight over time, we
included 1,937 patients (Fig. 1). The results from the mul-
tilevel model are shown in Table 2. The estimated average
weight for 70-year old male patients (reference patient)
with an initial PA level of ‘‘Deficient’’ was 88.67 kg at
the beginning of the observation period. Female patients
were 7.92 kg lighter than male patients (P! 0.001). Also,
younger patients were heavier compared with the elderly
(þ3.98 kg for every 10 years below the age of 70; P!
0.001). Individuals with a ‘‘Deficient’’ initial PA level were
3.77 kg heavier than those with a ‘‘Healthy’’ initial PA level
(P! 0.001). The initial weight of the patients did notTable 1. Patient characteristics at study entry
Characteristics Study entry (n[ 2,549)





Weight, kg 83.9 (26.9)
Systolic blood pressure, mmHg 143.7 (20.3)
Abdominal circumference, cm 102.7 (11.8)
Total cholesterol, mmol/l 4.6 (1.1)
Body length, cm 167.4 (10.2)
BMI, kg/m2 30.0 (5.4)
Fasting glucose, mmol/l 7.7 (2.3)
HbA1c, % 6.8 (1.2)
Creatinine, umol/l 79.1 (21.3)
LDL cholesterol, mmol/l 2.9 (1.0)
Abbreviations: BMI, body mass index; HbA1c, Hemoglobin A1c;
LDL, low-density lipoprotein.
Data are presented as means (SD), unless otherwise stated.depend on the day of the first measurement during the ob-
servation period (P5 0.537).
On average, weight did not change statistically signifi-
cant during the observation period (þ0.07 kg over 972
days; P5 0.832). The change in weight was not signifi-
cantly different for female patients (P5 0.868) when com-
pared with males. However, age showed a quadratic
interaction with the course of weight during the observation
period (P5 0.024). In particular, younger (29 years) and
elderly patients (71 years) tended to lose more (or gainFig. 3. Plot of repeated measurements of weight over time. Thick
black line: loess smoother to visualize the model-free overall trend
of the weight data. Thin black lines: illustration of the course of weight
over time of four patients.
Fig. 4. Plot of repeated measurements of HbA1c over time. Thick
black line: loess smoother to visualize the model-free overall trend
of the HbA1c data. Thin black lines: illustration of the course of
HbA1c over time of four patients.
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between the ages 30 and 70 tended to gain more (or lose
less) weight. Patients who changed their PA level from
‘‘Deficient to Sportive’’ lost on average more weight (i.e.,
4.33 kg more weight loss over 972 days) when compared
with patients who stayed at a ‘‘Deficient’’ level (P5
0.004). In fact, patients with this PA-change level lost sta-
tistically significant more weight when compared with all
other PA-change levels (all P! 0.018), except for patients
who changed their PA level from ‘‘Healthy to Sportive’’
(P5 0.057) (data not shown in the table). Finally, most
of the random variability in intercepts and slopes could
be attributed to the patient as opposed to the general prac-
titioner level of the model. In particular, 99.1% of the var-
iability in the intercepts and 98.7% of the variability in the
slopes were because of differences between patients (data
not shown in the table).
For the analyses of changes of HbA1c over time, we in-
cluded 1,615 patients (Fig. 1). The results from the multi-
level model for HbA1c are shown in Table 2. The
estimated average HbA1c for 70-year old male patients with
an initial PA level of ‘‘Deficient’’ was 6.87% at the beginning
of the observation period. Younger patients had a higher stat-
ing HbA1c compared with elderly (þ0.07% for every 10
years below the age of 70; P! 0.001). Patients who had
their first measurement of HbA1c later in the follow-up pe-
riod had a lower starting value than patients who had their
first measurement earlier during the period (i.e., 0.15%
for patients who had the first measurement halfway through
the observation period (0.5xe0.30%) compared with those
who had the first measurement at the first day of the period;P5 0.013). Patients with a ‘‘Deficient’’ initial PA level had
on average aþ0.14% higher starting HbA1c than those with
a ‘‘Healthy’’ initial PA level (P! 0.001) and a þ0.23%
higher starting HbA1c than those with a ‘‘Sportive’’ initial
PA level (P5 0.004). The starting value did not depend on
the gender of the patient (P5 0.102).
Change in the average HbA1c was not statistically sig-
nificant during the observation period (þ0.03% over 972
days; P5 0.657). Again, a quadratic effect of age on the
slope appeared to be present in the data (P5 0.038), with
HbA1c tending to decrease more (or increase less) for pa-
tients between 71 and 93 years of age and tending to in-
crease more (or decrease less) for patients below or above
that range. Gender had no statistically significant effect
on the slope (P5 0.531). Patients who improved their PA
level from ‘‘Deficient to Sportive’’ or from ‘‘Deficient to
Healthy’’ decreased their HbA1c significantly (0.72%;
P5 0.006 and 0.25%; P5 0.003, respectively). In fact,
in patients with PA-change level ‘‘Deficient to Sportive,’’
HbA1c decreased significantly more when compared with
the other PA-change levels (all P! 0.024), except for pa-
tients who changed their PA level from ‘‘Deficient to
Healthy’’ (P5 0.080) and from ‘‘Healthy to Sportive’’
(P5 0.289) (data not shown in the table). Finally, the ran-
dom variability in the intercepts and slopes was again
mostly attributable to differences between patients and
not general practitioners (95.8% and 97.4% for the inter-
cepts and slopes, respectively: data not shown in the table).4. Discussion
4.1. Summary of results
We evaluated the effects of the currently provided care
for patients with T2DM in primary care on the course of
weight and HbA1c. We found that the average weight did
not change during the observation period of 972 days, nei-
ther did average HbA1c. In addition, most of the patients
did not change their PA level. Most patients did not exer-
cise enough, and only a few patients exercised more than
the minimum healthy level. Only in a subgroup of patients
who improved their PA level, we found statistically signif-
icant positive trends of weight and HbA1c. Any differences
in the course of weight and HbA1c were predominantly
influenced by random variability at the patient level; health
care providers seemed to have very little influence.
4.2. Comparison with existing literature
When the results of our study on the course of weight and
HbA1c are compared with those of the control group in life-
style trials, it shows that changes in weight [10,33e36] and
HbA1c [10,33e35] in controls in these trials also are usually
small and not statistically significant. However, usual care in
a clinical trial setting may not be the same as the usual care
in real-world primary care. The use of the electronic primary
Table 2. Results from the multilevel model for weight and HbA1c
Covariates
Weight HbA1c
Coefficient (95% CI) (in kg) P Coefficient (95% CI) (in %) P
Intercept 88.669 (87.234 to 90.104) !0.001 6.872 (6.774 to 6.971) !0.001
Day of first measurementa 1.104 (4.612 to 2.404) 0.537 0.303 (0.082 to 0.014) 0.013
Gender
Male 0 0
Female 7.916 (9.272 to 6.560) !0.001 0.067 (0.147 to 0.013) 0.102
Ageb 3.980 (4.555 to 3.405) !0.001 0.065 (0.100 to 0.030) !0.001
Initial PA level
Deficient 0 0
Healthy 3.772 (5.173 to 2.370) !0.001 0.140 (0.223 to 0.056) 0.001
Sportive 1.199 (3.896 to 1.499) 0.384 0.231 (0.390 to 0.072) 0.004
Slope
Day (after first measurement)a 0.071 (0.583 to 0.724) 0.832 0.027 (0.092 to 0.146) 0.657
Gender
Male 0 0
Female 0.048 (0.614 to 0.517) 0.868 0.035 (0.074 to 0.456) 0.531
Ageb 0.773 (1.052 to 0.493) !0.001 0.066 (0.117 to 0.016) 0.010
(Age2)b 0.191 (0.357 to 0.025) 0.024 0.029 (0.243 to 0.300) 0.038
PA-change level
Deficient / Deficient 0 0
Deficient / Healthy 0.682 (1.641 to 0.277) 0.163 0.252 (0.416 to 0.089) 0.003
Deficient / Sportive 4.326 (7.286 to 1.367) 0.004 0.723 (1.238 to 0.208) 0.006
Healthy / Deficient 0.265 (0.608 to 1.137) 0.552 0.111 (0.041 to 0.264) 0.154
Healthy / Healthy 0.530 (1.241 to 0.180) 0.143 0.109 (0.241 to 0.023) 0.105
Healthy / Sportive 0.628 (3.148 to 1.893) 0.625 0.367 (0.796 to 0.061) 0.093
Sportive / Deficient 0.737 (1.522 to 2.997) 0.522 0.164 (0.235 to 0.563) 0.421
Sportive / Healthy 0.095 (1.650 to 1.459) 0.904 0.091 (0.188 to 0.371) 0.522
Sportive / Sportive 1.147 (0.683 to 2.978) 0.219 0.029 (0.368 to 0.310) 0.868
Abbreviation: CI, confidence interval.
Reference: male, 70 years old, initial PA level ‘‘Deficient,’’ PA-change level ‘‘Deficient / Deficient.’’
a Day of first measurement and day (after first measurement) per 972 days.
b Age centered at 70 years and per 10 years.
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usual care without the Hawthorne-like effects that could
be expected in analyses of research settings [23].
To really achieve lifestyle effects in routine primary
care, effective experimental lifestyle programs should be-
come usual care within time. Translation studies [22] and
the results of this article show that lifestyle programs in
usual care settings are not as successful as the programs
in clinical trial settings. There may be several reasons for
this lack of translation of evidence from trial setting into
the daily primary care setting. One reason may be that it
is very difficult for policy makers to work with evidence-
based medicine when it comes to nonpharmacological
interventions. It may be difficult to find or choose that spe-
cific trial applicable for a certain situation, even with the
availability of systematic reviews [25]. Another reason
may be that there is little time for health care providers
for lifestyle management in daily practice, because of the
current structure of the diabetes management programs,
which focus on diabetes indicators and medical treatment
and not on lifestyle.
In type 2 diabetics, exercise may have positive effects on
HbA1c levels, but it is uncertain to what extent exercise re-
ally influences weight in diabetic patients [5,8,37]. It hasbeen shown that exercise has beneficial effects on health-
related outcomes and glycemic control, independent from
changes in body weight [5,38]. However, our results show
that more people decrease than increase their PA level
and that only a very limited number of patients have a high-
er PA level than minimally required. Therefore, patients
may not achieve sufficiently high PA levels to improve
health outcomes. Previous research showing that exercise
programs in primary care have limited effects on increasing
PA [39e42] confirms the lack of effectiveness of such pro-
grams in real-world settings.4.3. Strengths and limitations
This study is not a fully comprehensive research to inves-
tigate the effectiveness of all lifestyle programs in primary
care. Nor is this manuscript a complete solution to the prob-
lems of translating evidence from trial settings into real-
world primary care. This study is only part of the puzzle.
Other research questions are imaginable, such as how much
of the available evidence is at least considered for imple-
mentation in primary care. In addition, we did not fully in-
vestigate all pros and cons of using electronic medical
records for research. We propose a feasible method to use
791J.J. Linmans et al. / Journal of Clinical Epidemiology 65 (2012) 785e792these data to evaluate the effectiveness of real-world pri-
mary care. Nevertheless, we do suggest that this manuscript
highlights the importance, the difficulties, and maybe some
solutions of these issues that both daily practice and daily
research struggle with.
Because we used the electronic primary care records for
data abstraction, missing values were inevitable. We had no
data on PA of 610 patients. This could bias the results if the
assessment depended on the outcome measurement (i.e.,
missing data may be missing not at random). However,
all centers used the same diabetes management program,
which describes in detail the variables that should be mea-
sured and when they should be measured. When patients
significantly improve their PA level, they presumably
would have little reason to withhold that information from
their health care provider. Besides, patients tend to overes-
timate their PA level. Therefore, it is more likely that the
results are false positive rather than false negative. The
small number of patients within the ‘‘Sportive’’ PA level
may indicate a realistic distribution into categories.
Our results show that patients in subgroups who im-
proved their PA level lost weight and lowered their HbA1c.
However, we cannot conclude that these improvements
were caused by their increase in exercise. It is likely that
these patients improved multiple facets of their lifestyle
and not only the amount of exercise. Besides, we did not
take medication use into account. Because our results show
that the currently provided care is able to stabilize HbA1c
levels without improving PA levels and weight, we can as-
sume that medication usage influenced HbA1c levels.
We did not include a control condition in our evaluation.
As we wanted to evaluate real-world usual care for all type
2 diabetics, we did not differentiate between (preventive)
lifestyle programs that could have started implementing
in practice during the observational period. In addition,
some [39] but probably not all individual programs could
be made visible when using only data from electronic pri-
mary care records. Therefore, we cannot rule out that some
evidence from trials did translate into routine daily care and
that the situation would have been worse otherwise. Now
that electronic primary care records are available and the
registration is adequate, future studies should show whether
the situation changes over the years.5. Conclusions
Currently provided care for patients with T2DM in pri-
mary care stabilizes but not decrease weight and HbA1c.
In addition, most patients remain physically inactive. There
is an evidence gap between effective lifestyle interventions
in clinical trial settings and real-world primary care. There-
fore, to really intervene in the growing pandemic of diabe-
tes, the real challenge is to develop and implement effective
lifestyle programs in primary care. To demonstrate the ac-
tual effectiveness of lifestyle interventions in primary care,future studies should take place in primary care networks
with solid medical registration systems.Acknowledgments
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